1910 Genetics Receives NIH Phase I STTR Grant for Discovery of Novel Non-Opioid Drugs for Chronic Pain

  • 1 min read
  • 30th September, 2021
  • Company Issued Releases
  • 1910 Genetics
read more
  • Company Issued Releases(2)
  • Explore other topics
Company Issued Releases
1910 Genetics Debuts with $26M to Accelerate the Design of Small Molecule and Protein Therapeutics Through AI, Computation and Biological Automation
6m read 23rd March, 2021.